Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients. - sprookjes - yvandenbroek - TriplyDB

Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients.

Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients.

http://www.wikidata.org/entity/Q40938494

about

The Role of Glycosylation in Breast Cancer Metastasis and Cancer Control Loss of Core 1-derived O-Glycans Decreases Breast Cancer Development in Mice Lewis x Antigen is Associated to Head and Neck Squamous Cell Carcinoma Survival.Role of HYAL1 expression in primary breast cancer in the formation of brain metastases.Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer.Longitudinal Transcriptional Response of Glycosylation-Related Genes, Regulators, and Targets in Cancer Cell Lines Treated With 11 Antitumor Agents.An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer.Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer.Clinicopathological significance of ganglioside DSGb5 expression in renal cell carcinoma.LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1.

P2860

Q26777141-FD6BAB15-C4AB-4FD6-93FC-5EF4615B42B6 Q35953085-19B565A5-E026-4FBC-88B2-4FEE9007B8A8 Q38691856-517325B2-470A-4DB2-B1D6-E624F1A98C1D Q38974913-27DB58D1-5578-49AA-A767-CAD7E21A2457 Q40108489-14E0351A-BE4E-42F7-A767-5D251AA65A44 Q47120271-21C52AB3-41B2-484A-A431-8B704C97CB74 Q47134338-DC5AD01B-0531-47B3-9EB8-2BB3A9A6A0EE Q47831739-FB6483DF-7DDD-413F-B9B1-193262DAFFC9 Q51135772-12E0AB9D-6A52-464B-9124-AA87D5009357 Q55348071-692CF21D-8FC9-49D8-8D2A-37B3D8FD7969

P2860

Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients.

http://www.wikidata.org/entity/Q40938494

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Relevance of βGal-βGalNAc-cont ...... val in breast cancer patients.

@en

type

label

Relevance of βGal-βGalNAc-cont ...... val in breast cancer patients.

@en

prefLabel

Relevance of βGal-βGalNAc-cont ...... val in breast cancer patients.

@en

P1433

Q40938494-9F29945B-8325-4CDF-92B8-DD41267F56D8

P1476

Q40938494-859AA387-ED16-431A-88A4-BFBC13F56FD1

P2093

Q40938494-053EDEF8-D935-4523-813F-2C7EB069CE67

Q40938494-257CA8A8-4415-4CFC-AF79-3AFCB34C0F5D

Q40938494-387C10E3-3891-4041-AFC9-06C964629E30

Q40938494-39262C43-83E3-438F-8A57-096B18DF15C6

Q40938494-407C1D2B-5340-4657-9E63-6F748BCFF4A6

Q40938494-6557140A-5280-4178-8AD9-53132101FBEC

Q40938494-C16CF329-5CDD-4EE5-9F60-5A36BBA371EB

Q40938494-D7325147-7D11-4B2F-B2DB-8B2BE9C850C4

Q40938494-E05929B8-D587-412F-8920-E7742A5F6B46

P2860

Q40938494-08D0120C-33C2-46C6-B7D0-73AEC425943D

Q40938494-104F1546-E888-4705-8ED5-41C2403320D4

Q40938494-175CC675-585E-4308-A945-EE162B292178

Q40938494-175FC61B-05BD-4666-B496-600C8C2AD052

Q40938494-17B058F9-4588-4EFB-A94D-BBFE0EB6711B

Q40938494-25B7EC6A-54A5-44B3-89CA-B1FDA027C912

Q40938494-2D146043-306A-4BB5-BADA-6D091F9DAA18

Q40938494-31F2E2A2-1010-470F-8E5D-2564E890AD9F

Q40938494-3E071AA9-D702-4472-8DF5-C392A836C6B9

Q40938494-575F9C6A-DA47-4A72-AB9E-980DECF33A96

P2888

Q40938494-84DA0C31-8717-446A-B553-2BF8803EF573

P304

Q40938494-6DA05D3B-2BE3-4B83-BE67-41C61BB33321

P31

Q40938494-A4CBFCA2-78AF-4489-A615-C6B40B4CD8E9

P356

Q40938494-4C21F8D6-E763-42F0-AABE-B713D9B5B5A6

P407

Q40938494-0ABEE315-7A65-44B8-9C72-28B5F8C1BA1F

P433

Q40938494-E22E5669-0B65-4EBF-A8B5-2B5F3AF0C7C7

P478

Q40938494-5FD01139-1176-47D0-9595-D2EE7E6245D2

P50

Q40938494-090F6EA8-362D-404D-A41A-048AA8608F14

P577

Q40938494-EAB39741-436A-435E-AC6E-C78DCC98639B

P5875

Q40938494-235EE263-6918-488E-9C58-D5AD5F85BAFB

P6179

Q40938494-9C2EA361-D696-48D3-9AFA-17333385769B

P698

Q40938494-A18DABB1-1755-476D-80E7-5EA165CFD8A3

P356

S10549-015-3425-0

P1433

Breast Cancer Research and Treatment

P1476

Relevance of βGal-βGalNAc-cont ...... val in breast cancer patients.

@en

P2093

Christine Schröder

http://www.w3.org/2001/XMLSchema#string

Dina Schütze

http://www.w3.org/2001/XMLSchema#string

Isabell Witzel

http://www.w3.org/2001/XMLSchema#string

Karin Milde-Langosch

http://www.w3.org/2001/XMLSchema#string

Klaus Pantel

http://www.w3.org/2001/XMLSchema#string

Leticia Oliveira-Ferrer

http://www.w3.org/2001/XMLSchema#string

Patrick Lebok

http://www.w3.org/2001/XMLSchema#string

Udo Schumacher

http://www.w3.org/2001/XMLSchema#string

Volkmar Müller

http://www.w3.org/2001/XMLSchema#string

P2860

C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma

C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.

C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity

Primary breast cancer tumours contain high amounts of IgA1 immunoglobulin: an immunohistochemical analysis of a possible carrier of the tumour-associated Tn antigen.

Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin

Prognostic significance of Helix pomatia lectin and c-erbB-2 oncoprotein in human breast cancer.

Helix pomatia and Ulex europeus lectin binding in human breast carcinoma.

Lectin binding to cutaneous malignant melanoma: HPA is associated with metastasis formation.

Lectins for histochemical demonstration of glycans.

Cell surface protein glycosylation in cancer.

P2888

s10549-015-3425-0

P304

515-528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-015-3425-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

151

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276358035

http://www.w3.org/2001/XMLSchema#string

P6179

1044544149

http://www.w3.org/2001/XMLSchema#string

P698

25975956

http://www.w3.org/2001/XMLSchema#string